losartan has been researched along with 1-methyl-3-isobutylxanthine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brønd, L; Christensen, S; Hadrup, N; Jonassen, TE; Nielsen, JB; Nielsen, S; Praetorius, J; Torp, M | 1 |
1 other study(ies) available for losartan and 1-methyl-3-isobutylxanthine
Article | Year |
---|---|
Losartan decreases vasopressin-mediated cAMP accumulation in the thick ascending limb of the loop of Henle in rats with congestive heart failure.
Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclases; Angiotensin II Type 1 Receptor Blockers; Animals; Cyclic AMP; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Failure; Kidney Cortex; Kidney Medulla; Loop of Henle; Losartan; Male; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Sodium-Potassium-Chloride Symporters; Sodium-Potassium-Exchanging ATPase; Solute Carrier Family 12, Member 1; Vasopressins | 2007 |